Convalescent anti-SARS-CoV-2 plasma for the treatment of patients with COVID-19: a retrospective study RESCOVID-19
Our study demonstrated that the administration of CP was safe and possibly associated with positive effects that were more pronounced if CP was administered within the first three days after the onset of COVID-19 symptoms.
Authors
- Šárka Blahutová (ORCID: https://orcid.org/0000-0001-7598-8891)
- David Řezáč (ORCID: https://orcid.org/0000-0003-4089-8938)
- Ivan Rychlı́k (ORCID: https://orcid.org/0000-0001-7995-6483)
- Anna Burantová
- Jan Máca (ORCID: https://orcid.org/0000-0002-9771-0468)
- Miloš Bohoněk (ORCID: https://orcid.org/0000-0001-6774-2648)
- Kateřina Volfová
- Michal Holub (ORCID: https://orcid.org/0000-0003-1894-2605)
- Petr Štěpánek (ORCID: https://orcid.org/0000-0001-8956-5590)
- Aleš Chrdle (ORCID: https://orcid.org/0000-0003-4572-745X)
- Dominik Kutáč (ORCID: https://orcid.org/0000-0001-5689-2456)
- Jiří Sagan
- Kateřina Vonášková
- Radek Majerčin
- Pavel Vabroušek
- Jan Kubů
- Radka Králová
- Viktor Fridrich
Institutions
- University of Ostrava (CZ)
- Charles University (CZ)
- Fakultní nemocnice Bulovka (CZ)
- University of South Bohemia in České Budějovice (CZ)
- University Hospital Ostrava (CZ)
- Nemocnice České Budějovice (CZ)
- Military University Hospital Prague (CZ)
- University Hospital Hradec Králové (CZ)
- University Hospital Kralovske Vinohrady (CZ)
- Czech Academy of Sciences, Institute of Physiology (CZ)
- Czech Technical University in Prague (CZ)
- Resuscitation Council (GB)
Publication Details
- Journal
- Virology Journal
- Published
- 2024-09-30
- DOI
- https://doi.org/10.1186/s12985-024-02475-y
- Citations
- 4
- Primary Topic
- COVID-19 Clinical Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 1.56
Funders
- Ministry of Defense
- Ministerstvo Obrany České Republiky